ALICIA BUCK: Open Payments
NPI 1649996828 · HICKORY, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,367 in 179 payments from 17 companies in 2025. Trend: 2023 $2,533 · 2024 $3,282 · 2025 $3,367
Food & beverage: $3,279Education: $87
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 66 | $668 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 19 | $451 |
| Vanda Pharmaceuticals Inc. | 14 | $354 |
| Otsuka America Pharmaceutical, Inc. | 15 | $341 |
| Neurocrine BioSciences, Inc. | 12 | $287 |
| Teva Pharmaceuticals USA, Inc. | 8 | $251 |
| Alkermes, Inc. | 10 | $205 |
| E.R. Squibb & Sons, L.L.C. | 10 | $178 |
| Supernus Pharmaceuticals, Inc. | 5 | $138 |
| Axsome Therapeutics, Inc. | 1 | $124 |
Products named: VRAYLAR, CAPLYTA, FANAPT, INGREZZA, REXULTI, COBENFY, Qelbree, LYBALVI.
Industry payments across NC — which companies pay providers there.
